Yungjin Pharm. Co., Ltd. (KRX:003520)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,966.00
-10.00 (-0.51%)
At close: Dec 5, 2025

Yungjin Pharm. Market Cap

Yungjin Pharm. has a market cap or net worth of 359.57 billion as of December 5, 2025. Its market cap has decreased by -11.64% in one year.

Market Cap
359.57B
Enterprise Value
n/a
Revenue
158.79B
Ranking
n/a
PE Ratio
36.75
Stock Price
1,966.00

Market Cap Chart

Since April 16, 1993, Yungjin Pharm.'s market cap has increased from 61.80B to 359.57B, an increase of 481.79%. That is a compound annual growth rate of 5.54%.

History

DateMarket Cap% Change
Dec 5, 2025359.57B-1.11%
Dec 30, 2024363.59B-6.45%
Dec 28, 2023388.65B-34.62%
Dec 29, 2022594.40B-38.56%
Dec 30, 2021967.50B-34.20%
Dec 30, 20201,470.46B21.27%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 28, 2017 Pro Pro
Dec 29, 2016 Pro Pro
Dec 30, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Samsung Biologics 77.77T
Celltrion 39.95T
ALTEOGEN 27.76T
ABL Bio 11.08T
SK Biopharmaceuticals 10.61T
Yuhan 8,836.80B
LigaChem Biosciences 7,139.05B
Peptron 6,540.52B
Market Cap Rankings